BLU-222 is an orally available but selective cell cycle protein-dependent kinase (CDK2) inhibitor with antitumor activity for the study of ovarian and uterine cancer.
Molecular Weight:
365.34
Purity:
99.17%
CAS Number:
[2888704-84-3]
Formula:
C15H17F2N7O2
Target:
CDK|||Apoptosis
T84321
* VAT and and shipping costs not included. Errors and price changes excepted